View All Patents
EP3175863
VARIANTS OF C-TYPE NATRIURETIC PEPTIDE
Filed
May 20, 2010
Technology
Chemistry · Pharmaceuticals +2
UPC cases
3
EPO proceedings
2
Ownership history
As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.
- BioMarin Pharmaceutical Inc.since Jun 15, 2017
Abstract
The present disclosure provides variants of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising CNP variants, and methods of making CNP variants. The CNP variants are useful as therapeutic agents for the treatment of diseases responsive to CNP, including but not limited to bone-related disorders, such as skeletal dysplasias (e.g., achondroplasia), and vascular smooth muscle disorders (e.g., restenosis and arteriosclerosis).
Litigation history
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Jun 2, 2025 | UPC CFI 18/2025 | Munich LD | Infringement | Locked | BioMarin Pharmaceutical Inc. +2 |
Additional proceedings on this patent
Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in